CMA
MLAB icon

Cedar Mountain Advisors’s Mesa Laboratories MLAB Stock Holding History

Cedar Mountain Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$996 Hold
10
– – ﹤0.01% 948
2026
Q1 		$884 Hold
10
– – ﹤0.01% 929
2025
Q4 		$785 Hold
10
– – ﹤0.01% 555
2025
Q3 		$670 Buy
+10
New +$720 ﹤0.01% 576

Other funds holding MLAB

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
KPP
Kings Path Partners Sugar Land, Texas $376M AUM 19% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
HNB
Hilltop National Bank Casper, Wyoming $468M AUM 36.09% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Cedar Mountain Advisors's MLAB Position: Q2 2026 in Review

Cedar Mountain Advisors held its Mesa Laboratories (MLAB) position steady in Q2 2026 at 10 shares worth $996. The position accounts for ﹤0.01% of the portfolio, ranked #948.

Cedar Mountain Advisors first reported a position in MLAB in Q3 2025 and has held it in 4 quarters since. 10 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Cedar Mountain Advisors held 10 shares of Mesa Laboratories worth $996 as of Q2 2026.
  • Cedar Mountain Advisors left its Mesa Laboratories share count unchanged in Q2 2026.
  • Mesa Laboratories made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #948 holding.
  • Cedar Mountain Advisors first reported a position in Mesa Laboratories in Q3 2025 and has held it in 4 quarters since.
  • 10 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.